FREE SELF-ASSESSMENT · CDC & CSTE ALIGNED
Drug Diversion Prevention Program Assessment
A free self-assessment for hospital, community and multi-site pharmacy teams — score your diversion prevention program, and explore 724 documented cases, every one sourced to a board action, a court filing or a press release.
No account or login. Progress saves in your browser.
Investigating a suspected case right now? Open the Investigation Playbook.
- Governance
- Lifecycle controls
- Surveillance
- Waste documentation
- 2 gaps to review
THE REGISTRY
See the full statistics page for every chart, the ranked table of all states and territories, and every case listed state by state.
START HERE
Choose Your Assessment
Every checklist includes: Real-time scoring Auto-save CSV & PDF export
FREE DOWNLOAD
Download the Prevention Value Deck
The registry data, the warning signs and the case findings in one shareable slide deck — built for training sessions and leadership briefings. Every figure is cited to a public record.
What is in it
- What the public record actually shows
- Where documented exposure concentrates
- The five handling stages, and the control at each
- A 90-day plan you can put to a board
THE BASICS
What Is Drug Diversion & Why It Matters
Patient Safety
Diverted injectable drugs have caused hepatitis B/C and HIV outbreaks in healthcare settings. Impaired providers endanger patients and erode care quality (CDC).
Documented Outbreaks
CDC recorded outbreaks from 1983–2018: 45 HCV infections (NH/KS/MD, 2012), 45 cases (TX, 1992), 25 cases (MN, 2011), 18 HCV (CO, 2009).
Substantially Underreported
Diversion is substantially underestimated and underreported across U.S. healthcare facilities — most incidents never surface through formal channels. Only cases that become a public record appear in the registry, so its own counts are a floor rather than a total.
WHAT TO WATCH FOR
Early Warning Signs (CSTE Behavioral Patterns)
- Unscheduled absences or arriving and leaving at unusual hours
- Frequent unexplained disappearances from the worksite
- Insisting on personally administering injectable medications
- Abnormal waste patterns — excessive, incomplete, or unwitnessed waste documentation
- Volunteering for overtime, particularly near shift-end when oversight is reduced
CAPABILITIES
What You Can Do
Run a self-assessment
Hospital, community, or multi-system with per-site scoring
Track scores over time
Real-time scoring with auto-save and CSV export
Export to PDF
Download checklist results as PDF for reporting
Run an investigation
Use the playbook, interview guide, and filing guide
THE PUBLIC RECORD
Not every investigated case reaches the registry
A diversion is rarely caught by one dramatic moment. It usually surfaces through something ordinary — a count that stops reconciling, a colleague or patient who raises it, an audit, a hotline tip, or a supplier, pharmacy or regulator asking a question.
What follows is a chain: an internal investigation, a report to a state board, the DEA or law enforcement, and then — only for some cases — a public record such as a board action or a court filing. The registry holds that last group only. A diversion that is found and investigated but never becomes public does not appear here, which is why the counts in it are a floor rather than a total.
Investigation playbook →CASE IN POINT
Latest Case Study: What Diversion Looks Like Now
Fort Walton Beach Gastroenterologist Pays $300,000 to Settle Controlled Substances Act Prescribing Allegations
A gastroenterologist practicing in Fort Walton Beach, Florida agreed to pay $300,000 to resolve allegations that he violated the Controlled Substances Act (CSA) by unlawfully prescribing opioids and other controlled substances. The government alleged that from June 15, 2023 through March 7, 2025, he unlawfully prescribed at least 127 controlled-substance prescriptions in Florida — including oxycodone-acetaminophen, hydrocodone-acetaminophen, lorazepam, alprazolam, clonazepam, and tramadol — and did not maintain any patient records. He voluntarily surrendered his DEA registration on April 22, 2026. As part of the settlement, announced September 21, 2026, he agreed not to reapply for a DEA registration for Schedule II or IIN controlled substances, to document completion of continuing medical education in prescribing and recordkeeping, and to additional DEA monitoring. This civil settlement is not an admission of liability.
More Recent Cases
SOURCING & AUTHOR
Built by a diversion program manager, every case sourced to a public record
Alex Rodriguez, MHIIM, CPhT, is a drug diversion prevention program manager with more than 10 years of pharmacy experience spanning retail, hospice, compounding, home-health, and hospital settings.
- Published author — Pharmacy Purchasing & Products Magazine
- Faculty — ASHP Drug Diversion Certificate program, 21 contact hours of CE
- Speaker — Health Care Compliance Association
Every case in the registry comes from a public record — a state board disciplinary action, a court filing or a press release — and each one links to that source.
A diversion that is found and investigated but never becomes public does not appear here, so the counts are a floor rather than a total.
RESOURCES
Guides, tools and a peer network
Comparing drug diversion monitoring software?
Before you sit through a vendor demo, read our plain-language breakdown of what ADC analytics, EHR transaction surveillance, reconciliation, and anomaly-detection tools actually do — the mechanism behind each, what the data can and can't prove, and the questions worth asking before you sign.
NEWS & GUIDES
Latest from the Blog
Guides by topic: Drug Diversion Prevention Program · DEA Audit Readiness · Pharmacy Diversion Monitoring · Compounding and USP 795/797/800 · Drug Diversion Audit
FAQ
Frequently Asked Questions
CONTACT
Get in touch
Have a question, or see something that should be added or corrected? Send a message — we read everything.
DivertGuard is built and maintained by Alex Rodriguez, MHIIM, CPhT. More about the author →
Press Esc or click outside the chart to close.